Search

Your search keyword '"Yokoyama, Akihito"' showing total 879 results
Start Over Author "Yokoyama, Akihito"
879 results on '"Yokoyama, Akihito"'

1. Pulmonary function and chest CT abnormalities 3 months after discharge from COVID-19, 2020–2021: A nation-wide multicenter prospective cohort study from the Japanese respiratory society

Author

Kamata, Hirofumi, Takamatsu, Kazufumi, Fukunaga, Koichi, Chubachi, Shotaro, Nakagawara, Kensuke, Namkoong, Ho, Terai, Hideki, Tanaka, Katsushi, Sato, Susumu, Hagiwara, Eri, Takei, Reoto, Kondoh, Yasuhiro, Takazono, Takahiro, Hashimoto, Midori, Tasaka, Sadatomo, Ohrui, Takashi, Tanino, Yoshinori, Mineshita, Masamichi, Komase, Yuko, Miyazaki, Kazuhito, Nishikawa, Masanori, Ando, Akira, Kita, Hideo, Ichihara, Eiki, Ohshimo, Shinichiro, Murata, Yoriyuki, Ishida, Masayuki, Kobayashi, Seiichi, Uchida, Takahiro, Tateno, Hiroki, Ikari, Jun, Terashima, Takeshi, Kozu, Yutaka, Tateishi, Tomoya, Shinkai, Masaharu, Sagara, Hironori, To, Yasuo, Ito, Yoko, Yamamoto, Masaki, Yamamoto, Yoshihiro, Kita, Toshiyuki, Ito, Yutaka, Tomii, Keisuke, Fujita, Yukio, Funaki, Yoshihiro, Yatera, Kazuhiro, Yamasue, Mari, Komiya, Kosaku, Kozawa, Satoko, Manabe, Hideaki, Hozumi, Hironao, Horiguchi, Tomoya, Kitajima, Takamasa, Nakano, Yasushi, Nagaoka, Tetsutaro, Hojo, Masayuki, Ebihara, Akinori, Kobayashi, Masayoshi, Takayama, Koji, Jinta, Torahiko, Sawai, Toyomitsu, Fukuda, Yuichi, Kaneko, Takeshi, Chin, Kazuo, Ogura, Takashi, Mukae, Hiroshi, Ishii, Makoto, and Yokoyama, Akihito

Published
2024
Full Text
View/download PDF

9. Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes

Author

Nomura, Natsuko, Matsumoto, Hisako, Yokoyama, Akihito, Nishimura, Yoshihiro, Asano, Koichiro, Niimi, Akio, Tohda, Yuji, Harada, Norihiro, Nagase, Hiroyuki, Nagata, Makoto, Inoue, Hiromasa, Kondo, Mitsuko, Horiguchi, Takahiko, Miyahara, Nobuaki, Hizawa, Nobuyuki, Hojo, Masayuki, Hattori, Noboru, Hashimoto, Naozumi, Yamasaki, Akira, Kadowaki, Toru, Kimura, Tomoki, Miki, Mari, Taniguchi, Hirokazu, Toyoshima, Mikio, Kawamura, Tetsuji, Matsuno, Osamu, Sato, Yoko, Sunadome, Hironobu, Nagasaki, Tadao, Oguma, Tsuyoshi, and Hirai, Toyohiro

Published
2022
Full Text
View/download PDF

12. Myocardial Injury by COVID-19 Infection Assessed by Cardiovascular Magnetic Resonance Imaging ― A Prospective Multicenter Study ―

Author

Kato, Shingo, primary, Kitai, Takeshi, additional, Utsunomiya, Daisuke, additional, Azuma, Mai, additional, Fukui, Kazuki, additional, Hagiwara, Eri, additional, Ogura, Takashi, additional, Ishibashi, Yuki, additional, Okada, Taiji, additional, Kitakata, Hiroki, additional, Shiraishi, Yasuyuki, additional, Torii, Shunsuke, additional, Ohashi, Koichi, additional, Takamatsu, Kazufumi, additional, Yokoyama, Akihito, additional, Hirata, Ken-Ichi, additional, Matsue, Yuya, additional, and Node, Koichi, additional

Published
2024
Full Text
View/download PDF

16. The Japanese respiratory society guidelines for the management of cough and sputum (digest edition)

Author

Mukae, Hiroshi, Kaneko, Takeshi, Obase, Yasushi, Shinkai, Masaharu, Katsunuma, Toshio, Takeyama, Kiyoshi, Terada, Jiro, Niimi, Akio, Matsuse, Hiroto, Yatera, Kazuhiro, Yamamoto, Yoshihiro, Azuma, Arata, Arakawa, Hirokazu, Iwanaga, Takashi, Ogawa, Haruhiko, Kurahashi, Kiyoyasu, Gon, Yasuhiro, Sakamoto, Hirokazu, Shibata, Yoko, Tamada, Tsutomu, Nishioka, Yasuhiko, Haranaga, Shusaku, Fujieda, Shigeharu, Miyashita, Naoyuki, Mochizuki, Hiroyuki, Yokoyama, Akihito, Yoshihara, Shigemi, and Tamaoki, Jun

Published
2021
Full Text
View/download PDF

18. Japanese guidelines for adult asthma 2020

Author

Nakamura, Yoichi, Tamaoki, Jun, Nagase, Hiroyuki, Yamaguchi, Masao, Horiguchi, Takahiko, Hozawa, Soichiro, Ichinose, Masakazu, Iwanaga, Takashi, Kondo, Rieko, Nagata, Makoto, Yokoyama, Akihito, and Tohda, Yuji

Published
2020
Full Text
View/download PDF

27. Japanese guideline for the treatment of idiopathic pulmonary fibrosis

Author

Homma, Sakae, Bando, Masashi, Azuma, Arata, Sakamoto, Susumu, Sugino, Keishi, Ishii, Yoshiki, Izumi, Shinyu, Inase, Naohiko, Inoue, Yoshikazu, Ebina, Masahito, Ogura, Takashi, Kishi, Kazuma, Kishaba, Tomoo, Kido, Takashi, Gemma, Akihiko, Goto, Yoshihito, Sasaki, Shinichi, Johkoh, Takeshi, Suda, Takafumi, Takahashi, Kazuhisa, Takahashi, Hiroki, Taguchi, Yoshio, Date, Hiroshi, Taniguchi, Hiroyuki, Nakayama, Takeo, Nishioka, Yasuhiko, Hasegawa, Yoshinori, Hattori, Noboru, Fukuoka, Junya, Miyamoto, Atsushi, Mukae, Hiroshi, Yokoyama, Akihito, Yoshino, Ichiro, and Watanabe, Kentaro

Published
2018
Full Text
View/download PDF

28. Pulmonary cryptococcosis mimicking lung cancer with multiple lung metastases.

Author

Ohnishi, Hiroshi, Horino, Taro, Nakajima, Hideki, and Yokoyama, Akihito

Subjects
LUNG cancer, CRYPTOCOCCOSIS, PULMONARY nodules, MYCOBACTERIAL diseases, METASTASIS
Abstract

Key message: The differential diagnosis of a lung mass with multiple pulmonary nodules includes metastases of lung cancer, mycobacterial infections, and pulmonary mycosis. Pulmonary cryptococcosis should be recognized, especially in immunocompromised patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

32. Staphylococcus aureus enterotoxin sensitization involvement and its association with the CysLTR1 variant in different asthma phenotypes

Author

Matsumoto, Hisako, Kanemitsu, Yoshihiro, Nagasaki, Tadao, Tohda, Yuji, Horiguchi, Takahiko, Kita, Hideo, Kuwabara, Kazunobu, Tomii, Keisuke, Otsuka, Kojiro, Fujimura, Masaki, Ohkura, Noriyuki, Tomita, Katsuyuki, Yokoyama, Akihito, Ohnishi, Hiroshi, Nakano, Yasutaka, Oguma, Tetsuya, Hozawa, Soichiro, Izuhara, Yumi, Ito, Isao, Oguma, Tsuyoshi, Inoue, Hideki, Tajiri, Tomoko, Iwata, Toshiyuki, Ono, Junya, Ohta, Shoichiro, Hirota, Tomomitsu, Kawaguchi, Takahisa, Tamari, Mayumi, Yokoyama, Tetsuji, Tabara, Yasuharu, Matsuda, Fumihiko, Izuhara, Kenji, Niimi, Akio, and Mishima, Michiaki

Published
2017
Full Text
View/download PDF

34. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

Author

Hanania, Nicola A, Korenblat, Phillip, Chapman, Kenneth R, Bateman, Eric D, Kopecky, Petr, Paggiaro, Pierluigi, Yokoyama, Akihito, Olsson, Julie, Gray, Sarah, Holweg, Cecile T J, Eisner, Mark, Asare, Charles, Fischer, Saloumeh K, Peng, Kun, Putnam, Wendy S, and Matthews, John G

Published
2016
Full Text
View/download PDF

38. COVID-19 Cluster in the Hematology/Respirology Ward of a University Hospital during the Seventh Wave of the SARS-CoV-2 Pandemic in Japan: A Descriptive Study

Author

Ogasawara, Fumiya, primary, Yoshida, Shohei, additional, Yamane, Mayuka, additional, Takamatsu, Kazufumi, additional, Arakawa, Yu, additional, Nishida, Yoshie, additional, Komatsu, Megumi, additional, Yokoyama, Akihito, additional, Yamagishi, Yuka, additional, and Kojima, Kensuke, additional

Published
2023
Full Text
View/download PDF

44. Additional file 1 of Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes

Author

Nomura, Natsuko, Matsumoto, Hisako, Yokoyama, Akihito, Nishimura, Yoshihiro, Asano, Koichiro, Niimi, Akio, Tohda, Yuji, Harada, Norihiro, Nagase, Hiroyuki, Nagata, Makoto, Inoue, Hiromasa, Kondo, Mitsuko, Horiguchi, Takahiko, Miyahara, Nobuaki, Hizawa, Nobuyuki, Hojo, Masayuki, Hattori, Noboru, Hashimoto, Naozumi, Yamasaki, Akira, Kadowaki, Toru, Kimura, Tomoki, Miki, Mari, Taniguchi, Hirokazu, Toyoshima, Mikio, Kawamura, Tetsuji, Matsuno, Osamu, Sato, Yoko, Sunadome, Hironobu, Nagasaki, Tadao, Oguma, Tsuyoshi, and Hirai, Toyohiro

Abstract

Additional file 1: Figure S1. Transition patterns of inflammatory types in cases who were not receiving anti-type 2 biologics or regular oral corticosteroids (≥5 mg/day) and were followed up for ≥2 years (n = 51). Red flow indicates former type 2-high group (n = 15), yellow flow indicates former type 2-intermediate group (n = 21) and blue flow indicates former type 2-low inflammatory group (n = 15). Figure S2. Receiver operating characteristic (ROC) curve for current levels of exhaled nitric oxide (FeNO) that reflected the presence of A) gram-negative bacteria (GNB) and B) P. aeruginosa in the sputum. Detection rate of C) GNB and D) P. aeruginosa in the sputum according to the FeNO levels, as determined by ROC curve analysis. Figure S3. A) Modified Reiff score and B) number of lobes affected by bronchiolitis in low and high exhaled nitric oxide (FeNO) groups. Recent indices were analysed. Boxes and bars indicate upper, lower, and median quartiles. Figure S4. Patterns of cases with exacerbations requiring systemic corticosteroids (SCS) and antibiotics and bronchopneumonia, according to the transition patterns of inflammatory groups (p = 0.056 among the three groups). Red bar indicates cases with three types of episodes in the last 2 years, i.e., exacerbations requiring SCS and antibiotics, and bronchopneumonia; orange bar, exacerbations requiring SCS and antibiotics; yellow bar, exacerbations requiring SCS only: blue bar, bronchopneumonia and exacerbations requiring antibiotics; purple bar, bronchopneumonia only; green bar, exacerbations requiring antibiotics only. Complete answers were missing from two cases in the low-to-low group, four in the high’-to-low group, and eight in the high’-to-high’ group. Ratios of cases with exacerbation requiring antibiotics (p = 0.01) and bronchopneumonia (p = 0.006) were significantly different among the three groups. Figure S5. Changes in terms of A) inhaled corticosteroid (ICS) doses (equivalent to fluticasone propionate), B) modified Reiff scores, C) number of lobes affected by bronchiolitis, D) detection rates of gram-negative bacteria (GNB) in sputum and E) detection rates of P. aeruginosa in sputum over time. Blue line indicates low-to-low group, yellow line indicates high’-to-low group and pink line indicates high’-to-high’ group. The numbers of cases in the low-to-low, high’-to-low, and high’-to-high’ groups were 17/19/35 for A), 19/21/40 for B); 15/21/34 for C); 17/15/32 for D) and 17/15/32 for E). Figure S6. Transition patterns of airway lesions, i.e., bronchiectasis, bronchiolitis, and both, in cases followed for 2 years or more. A) In all cases regardless of type 2 inflammation level, purple flow indicates former bronchiectasis only (n = 17); orange flow, former bronchiolitis only (n = 36); green flow, bronchiectasis and bronchiolitis in the past (n = 63); B) current type 2-high group (n = 14), C) current type 2-intermediate group (n = 17) and D) current type 2-low group (n = 41). Figure S7. Trajectories of blood eosinophil counts of patients with ≥3 data points allocated to A) high’-to-high’, B) high’-to-low and C) low-to-low groups. Patients represented by grey and brown lines in A), who received oral corticosteroids or anti-type 2 biologics, or both, had elevated exhaled nitric oxide (>100 ppb), and they were allocated to the high’-to-high group. Table S1. Characteristics of patients who were and were not stratified. Table S2. Features related to asthma and comorbidities according to the current inflammatory types. Table S3. Most effective treatment evaluated by attending physicians. Table S4. Features related to asthma according to the transition patterns of inflammatory types.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results